Trial Profile
A comparison of fosaprepitant and droperidol for prevention of postoperative nausea and vomiting in patients undergoing craniotomy: a randomized double-blinded study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Sep 2015
Price :
$35
*
At a glance
- Drugs Droperidol (Primary) ; Fosaprepitant (Primary) ; Dexamethasone
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- Acronyms IFOSAC
- 27 Sep 2015 Status changed from recruiting to completed,as reported by University Hospital Medical Information Network - Japan record.
- 14 Sep 2012 New trial record